T1	DISO 702 713	metastásico
#1	AnnotatorNotes T1	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T2	CHEM 107 119	Tremelimumab
#2	AnnotatorNotes T2	C2351038; tremelimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T3	PROC 143 156	quimioterapia
#3	AnnotatorNotes T3	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T4	DISO 160 205	adenocarcinoma ductal de páncreas metastásico
T5	ANAT 185 193	páncreas
#4	AnnotatorNotes T5	C0030274; Pancreas; Body Part, Organ, or Organ Component | C1278931; Entire pancreas; Body Part, Organ, or Organ Component
T6	PROC 229 268	Ensayo fase II, abierto y multicéntrico
T7	PROC 1031 1040	irradiada
#5	AnnotatorNotes T7	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T8	PROC 293 304	monoterapia
#6	AnnotatorNotes T8	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T9	CHEM 326 338	tremelimumab
#7	AnnotatorNotes T9	C2351038; tremelimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T10	DISO 356 401	adenocarcinoma ductal de páncreas metastásico
T11	ANAT 381 389	páncreas
#8	AnnotatorNotes T11	C0030274; Pancreas; Body Part, Organ, or Organ Component | C1278931; Entire pancreas; Body Part, Organ, or Organ Component
T12	DISO 425 458	adenocarcinoma ductal de páncreas
T13	ANAT 450 458	páncreas
#9	AnnotatorNotes T13	C0030274; Pancreas; Body Part, Organ, or Organ Component | C1278931; Entire pancreas; Body Part, Organ, or Organ Component
T14	CHEM 272 280	MEDI4736
#10	AnnotatorNotes T14	C3641122; MEDI4736; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T15	PROC 655 676	tratamiento sistémico
T16	DISO 729 749	progresión del tumor
#11	AnnotatorNotes T16	C0178874; Tumor Progression; Neoplastic Process
T17	PROC 754 767	quimioterapia
#12	AnnotatorNotes T17	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T18	CHEM 818 822	5 FU
#13	AnnotatorNotes T18	C0016360; fluorouracil; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T19	CHEM 825 836	gemcitabina
#14	AnnotatorNotes T19	C0045093; gemcitabine; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T20	DISO 867 871	ACDP
T21	CHEM 955 969	quimioterápico
#15	AnnotatorNotes T21	C0003392; Antineoplastic Agents; Organic Chemical · Pharmacologic Substance
T22	DISO 1020 1026	lesión
#16	AnnotatorNotes T22	C0221198; Lesion; Finding
T23	ANAT 1155 1174	ganglios linfáticos
#17	AnnotatorNotes T23	C0024204; lymph nodes; Body Part, Organ, or Organ Component | C1269047; Entire lymph node; Body Part, Organ, or Organ Component
T24	PROC 1224 1248	tomografía computarizada
#18	AnnotatorNotes T24	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T25	PROC 1256 1276	resonancia magnética
#19	AnnotatorNotes T25	C0024485; Magnetic Resonance Imaging; Diagnostic Procedure
T26	PROC 1278 1280	RM
#20	AnnotatorNotes T26	C0024485; Magnetic Resonance Imaging; Diagnostic Procedure
T27	PROC 1371 1384	quimioterapia
#21	AnnotatorNotes T27	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T28	PROC 1387 1398	tratamiento
#22	AnnotatorNotes T28	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T29	CHEM 1449 1459	hormonales
#23	AnnotatorNotes T29	C0019932; Hormones; Hormone
T30	DISO 1464 1470	cáncer
#24	AnnotatorNotes T30	C0006826; Malignant Neoplasms; Neoplastic Process
T31	DISO 1490 1518	carcinomatosis leptomeníngea
#25	AnnotatorNotes T31	C0220654; Meningeal Carcinomatosis; Neoplastic Process
T32	DISO 1522 1529	Ascitis
#26	AnnotatorNotes T32	C0003962; Ascites; Disease or Syndrome
T33	PROC 1540 1552	intervención
#27	AnnotatorNotes T33	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T34	DISO 1557 1578	Metástasis cerebrales
#28	AnnotatorNotes T34	C0220650; Metastatic malignant neoplasm to brain; Neoplastic Process | C0555278; Cerebral metastasis; Neoplastic Process
T35	DISO 1581 1612	compresión de la médula espinal
#29	AnnotatorNotes T35	C0037926; Compression of spinal cord; Disease or Syndrome
T36	CHEM 57 65	MEDI4736
#30	AnnotatorNotes T36	C3641122; MEDI4736; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T37	ANAT 175 181	ductal
#31	AnnotatorNotes T37	C0687028; Duct (organ) structure; Body Part, Organ, or Organ Component
T38	ANAT 371 377	ductal
#32	AnnotatorNotes T38	C0687028; Duct (organ) structure; Body Part, Organ, or Organ Component
T39	ANAT 440 446	ductal
#33	AnnotatorNotes T39	C0687028; Duct (organ) structure; Body Part, Organ, or Organ Component
T40	PROC 606 630	régimen de quimioterapia
T41	DISO 920 933	metastatizado
#34	AnnotatorNotes T41	C0027627; Neoplasm Metastasis; Neoplastic Process | C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T42	PROC 947 969	régimen quimioterápico
T43	PROC 1250 1252	TC
#35	AnnotatorNotes T43	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T44	ANAT 1505 1518	leptomeníngea
#36	AnnotatorNotes T44	C0228126; Leptomeninges; Body Part, Organ, or Organ Component | C1284563; Entire leptomeninges; Body Part, Organ, or Organ Component
T45	ANAT 1568 1578	cerebrales
#37	AnnotatorNotes T45	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T46	ANAT 1598 1612	médula espinal
#38	AnnotatorNotes T46	C0037925; Spinal Cord; Body Part, Organ, or Organ Component | C1278836; Entire spinal cord; Body Part, Organ, or Organ Component
T47	DISO 528 532	ACDP
T48	DISO 685 689	ACDP
T49	Date 13 17	2015
T50	LIVB 342 351	pacientes
#39	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T51	LIVB 485 494	Pacientes
#40	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	Age 499 514	>  o =  18 años
T53	Neg_cue 578 580	no
T54	Neg_cue 935 937	No
T55	Neg_cue 1028 1030	no
T58	Neg_cue 1143 1150	excepto
T60	Quantifier_or_Qualifier 596 605	más de un
T61	Dose 938 946	más de 1
T56	CHEM 1403 1429	productos en investigación
#41	AnnotatorNotes T56	C0013230; Investigational New Drugs; Pharmacologic Substance
T57	CHEM 1431 1433	PI
#42	AnnotatorNotes T57	C0013230; Investigational New Drugs; Pharmacologic Substance
T59	PROC 544 573	histológica o citológicamente
#43	AnnotatorNotes T59	C1305671; Cytology procedure; Laboratory Procedure + C0344441; Histology Procedure; Laboratory Procedure
T62	PROC 883 912	histológica o citológicamente
#44	AnnotatorNotes T62	C1305671; Cytology procedure; Laboratory Procedure + C0344441; Histology Procedure; Laboratory Procedure
T63	PROC 981 983	EF
#45	AnnotatorNotes T63	C4525818; Clinical Performance Status; Health Care Activity | C3694602; functional status of patient; Therapeutic or Preventive Procedure
A1	Assertion T15 Negated
A2	Assertion T60 Negated
A3	Assertion T61 Negated
A4	Assertion T7 Negated
A5	Assertion T23 Negated
A6	Status T40 History_of
A7	Status T15 History_of
A8	Status T17 History_of
A9	Status T18 History_of
A10	Status T19 History_of
A11	Status T21 History_of
A12	Status T42 History_of
A13	Status T7 History_of
A14	Status T31 History_of
#46	AnnotatorNotes T6	C0282460; Phase 2 Clinical Trials; Research Activity + C1709323; Open Label Study; Research Activity + C1096776; Multicenter Study; Research Activity
#47	AnnotatorNotes T40	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
#48	AnnotatorNotes T42	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T64	Quantifier_or_Qualifier 81 85	solo
R1	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T64	
R2	Combined_with Arg1:T36 Arg2:T2	
T65	Quantifier_or_Qualifier 126 139	segunda línea
R3	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T65	
R4	Location_of Arg1:T37 Arg2:T4	
R5	Location_of Arg1:T5 Arg2:T4	
R6	Location_of Arg1:T11 Arg2:T10	
R7	Location_of Arg1:T38 Arg2:T10	
R8	Experiences Arg1:T50 Arg2:T10	
R9	Experiences Arg1:T50 Arg2:T14	
R10	Used_for Arg1:T14 Arg2:T8	
R11	Combined_with Arg1:T14 Arg2:T9	
R12	Location_of Arg1:T39 Arg2:T12	
R13	Location_of Arg1:T13 Arg2:T12	
R14	Has_Age Arg1:T51 Arg2:T52	
R15	Experiences Arg1:T51 Arg2:T47	
#49	AnnotatorNotes T47	C1335302; Pancreatic Ductal Adenocarcinoma; Neoplastic Process
#50	AnnotatorNotes T48	C1335302; Pancreatic Ductal Adenocarcinoma; Neoplastic Process
#51	AnnotatorNotes T20	C1335302; Pancreatic Ductal Adenocarcinoma; Neoplastic Process
R16	Before Arg1:T20 Arg2:T41	
R17	Before Arg1:T48 Arg2:T1	
R18	Before Arg1:T48 Arg2:T16	
R20	Experiences Arg1:T51 Arg2:T40	
R21	Has_Quantifier_or_Qualifier Arg1:T40 Arg2:T60	
R22	Experiences Arg1:T51 Arg2:T59	
R23	Negation Arg1:T53 Arg2:T60	
R24	Negation Arg1:T53 Arg2:T15	
R25	Experiences Arg1:T51 Arg2:T15	
R26	Experiences Arg1:T51 Arg2:T48	
R27	Experiences Arg1:T51 Arg2:T1	
R28	Experiences Arg1:T51 Arg2:T16	
R29	Experiences Arg1:T51 Arg2:T17	
T66	Observation 690 701	recidivante
#52	AnnotatorNotes T66	C2825055; Recurrence (disease attribute); Pathologic Function
R31	Has_Quantifier_or_Qualifier Arg1:T48 Arg2:T66	
T67	Quantifier_or_Qualifier 784 797	primera línea
R33	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T67	
R34	Used_for Arg1:T18 Arg2:T17	
R35	Used_for Arg1:T19 Arg2:T17	
R38	Negation Arg1:T54 Arg2:T61	
R39	Has_Dose_or_Strength Arg1:T21 Arg2:T61	
R40	Used_for Arg1:T21 Arg2:T42	
T68	Result_or_Value 998 1003	0 ó 1
T69	CONC 990 994	ECOG
#53	AnnotatorNotes T69	C1520224; ECOG performance status; Intellectual Product
R41	Used_for Arg1:T69 Arg2:T63	
R42	Has_Result_or_Value Arg1:T69 Arg2:T68	
T70	Quantifier_or_Qualifier 1009 1019	Al menos 1
R43	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T70	
R44	Negation Arg1:T55 Arg2:T7	
T71	Result_or_Value 1109 1120	> o = 10 mm
R45	Has_Result_or_Value Arg1:T22 Arg2:T71	
T72	CONC 1084 1103	en el momento basal
#54	AnnotatorNotes T72	C1442488; Baseline; Quantitative Concept (?)
R46	Overlap Arg1:T22 Arg2:T72	
R47	Negation Arg1:T58 Arg2:T23	
R48	Location_of Arg1:T23 Arg2:T22	
T73	Result_or_Value 1207 1218	> o = 15 mm
R49	Has_Result_or_Value Arg1:T23 Arg2:T73	
T74	Quantifier_or_Qualifier 1292 1312	apta para mediciones
R54	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T74	
#55	AnnotatorNotes T74	C1513040; Measurable; Functional Concept
R55	Used_for Arg1:T56 Arg2:T27	
R57	Used_for Arg1:T57 Arg2:T28	
R58	Used_for Arg1:T57 Arg2:T27	
R59	Has_Quantifier_or_Qualifier Arg1:T57 Arg2:T29	
R60	Has_Quantifier_or_Qualifier Arg1:T56 Arg2:T29	
T75	Quantifier_or_Qualifier 1436 1446	biológicos
#56	AnnotatorNotes T75	C0205460; biological; Qualitative Concept
R61	Has_Quantifier_or_Qualifier Arg1:T57 Arg2:T75	
R62	Has_Quantifier_or_Qualifier Arg1:T56 Arg2:T75	
R56	Used_for Arg1:T56 Arg2:T28	
R63	Location_of Arg1:T44 Arg2:T31	
R64	Location_of Arg1:T45 Arg2:T34	
R65	Location_of Arg1:T46 Arg2:T35	
T76	Quantifier_or_Qualifier 1054 1071	que pueda medirse
#57	AnnotatorNotes T76	C1513040; Measurable; Functional Concept
R66	Overlap Arg1:T76 Arg2:T72	
R67	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T76	
#58	AnnotatorNotes T15	C1515119; Systemic Therapy; Therapeutic or Preventive Procedure
#59	AnnotatorNotes T64	C0205171; Singular; Quantitative Concept
#60	AnnotatorNotes T12	C1335302; Pancreatic Ductal Adenocarcinoma; Neoplastic Process
#61	AnnotatorNotes T10	C5204113; Metastatic Pancreatic Ductal Adenocarcinoma; Neoplastic Process
#62	AnnotatorNotes T4	C5204113; Metastatic Pancreatic Ductal Adenocarcinoma; Neoplastic Process
A15	Experiencer T50 Patient
A16	Experiencer T51 Patient
